Get started
Author

Krishna R. Polu

TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function
2005 · Jochen Reiser, Krishna R Polu, et al. · Nature Genetics · 861
Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension
2025 · Manish Saxena, Luke Laffin, et al. · JAMA · 119
PDF
Peginesatide for Anemia in Patients with Chronic Kidney Disease Not Receiving Dialysis
2013 · Iain C. Macdougall, Robert Provenzano, et al. · New England Journal of Medicine · 117
PDF
Peginesatide in Patients with Anemia Undergoing Hemodialysis
2013 · Steven Fishbane, Brigitte Schiller, et al. · New England Journal of Medicine · 111
PDF
The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses
2022 · Samantha A. Chalmers, Rajalakshmy Ayilam Ramachandran, et al. · Journal of Clinical Investigation · 107
PDF
Probody therapeutics for targeting antibodies to diseased tissue
2014 · Krishna R Polu, Henry B Lowman · Expert Opinion on Biological Therapy · 88
Focal Segmental Glomerulosclerosis
2009 · Krishna R. Polu, Martin R. Pollak · Elsevier eBooks · 70
NPHS2variation in focal and segmental glomerulosclerosis
2008 · Stephen J Tonna, Alexander Needham, et al. · BMC Nephrology · 60
PDF
Dose-finding Study of Peginesatide for Anemia Correction in Chronic Kidney Disease Patients
2011 · Iain C. Macdougall, Andrzej Wiecek, et al. · Clinical Journal of the American Society of Nephrology · 28
Stress Fracture of the Humerus in a Collegiate Baseball Pitcher
1999 · Krishna R. Polu, Robert C. Schenck, et al. · The American Journal of Sports Medicine · 20
Needle in a Haystack
2006 · Krishna R. Polu, Myles Wolf · New England Journal of Medicine · 14
38 History of pulmonary exacerbations (PEx) as a predictor of response to nebulized levofloxacin compared with nebulized tobramycin
2016 · P. Flume, J.S. Elborn, et al. · Journal of Cystic Fibrosis · 10
An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients
2012 · Anatole Besarab, Steven N Zeig, et al. · BMC Nephrology · 10
PDF
37 Microbiologic changes observed over 6 months in a randomized, open-label comparison of inhaled levofloxacin and inhaled tobramycin in persons with cystic fibrosis and chronic P. aeruginosa (Pa) airway infection
2016 · D.R. VanDevanter, J.S. Eiborn, et al. · Journal of Cystic Fibrosis · 7
PDF
Abstract 2665: Transforming Notch ligands into tumor-antigen targets: A Probody-Drug Conjugate (PDC) targeting Jagged 1 and Jagged 2
2014 · Jason Sagert, Jim West, et al. · Cancer Research · 7
Abstract C158: Tumor-specific inhibition of jagged-dependent notch signaling using a Probody™ therapeutic.
2013 · Jason Sagert, James West, et al. · Molecular Cancer Therapeutics · 6
Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizumab, in Subjects with Newly Diagnosed Acute Graft Versus Host Disease
2019 · John Koreth, Saurabh Chhabra, et al. · Blood · 3
Fo015akb-6548, a Novel Hypoxia-inducible Factor Prolyl-hydroxylase Inhibitor (hif-phi) for the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis (nd-ckd)
2015 · Pablo E Pergola, Bruce Spinowitz, et al. · Nephrology Dialysis Transplantation · 2
33 Safety and Efficacy of Peginesatide for Treatment of Anemia in Hemodialysis Patients Previously on Epoetin Alfa or Beta
2011 · Anatole Besarab, Francesco Locatelli, et al. · American Journal of Kidney Diseases · 2
274 Safety and Efficacy of Peginesatide for Treatment of Anemia in Hemodialysis Patient Previously on Epoetin Alfa
2011 · Brigitte Schiller, Steven Zeig, et al. · American Journal of Kidney Diseases · 2
Pathogenesis and Management of Secondary Hyperparathyroidism
2007 · Krishna R. Polu, Ajay K. Singh · Springer eBooks · 2
Itolizumab, a Novel Anti-CD6 Therapy, in Systemic Lupus Erythematosus Patients: Interim Safety Results from the Phase 1b EQUALISE Dose-Escalation Study
2021 · Chaim Putterman, Richard Furie, et al. · Journal of the American Society of Nephrology · 1
Renal anaemia - CKD 1-5
2012 · D. Fliser, V. Shilo, et al. · Nephrology Dialysis Transplantation · 1
Corrigendum to ‘Design of the Reduction of Events with Darbepoetin Alfa in Heart Failure (RED-HF): A Phase III, Anaemia Correction, Morbidity–Mortality Trial’ [ Eur J Heart Fail 2009;11:795–801]
2010 · John J.V. McMurray, Inder S. Anand, et al. · European Journal of Heart Failure · 1
PDF
Itolizumab, a Novel Anti-CD6 Antibody, in Systemic Lupus Patients with Proteinuria: An Interim Subgroup Analysis from EQUALISE, a Phase 1b Study
2021 · Chaim Putterman, Richard Furie, et al. · Journal of the American Society of Nephrology
Works count: 30
Citation count: 1,649
H-index: 11
I10-index: 13
Year
Topic
Type